Nuclear interactions in heavy ion transport and event-based risk models
Abstract
The physical description of the passage of heavy ions in tissue and shielding materials is of interest in radiobiology, cancer therapy and space exploration, including a human mission to Mars. Galactic cosmic rays (GCRs) consist of a large number of ion types and energies. Energy loss processes occur continuously along the path of heavy ions and are well described by the linear energy transfer (LET), straggling and multiple scattering algorithms. Nuclear interactions lead to much larger energy deposition than atomic-molecular collisions and alter the composition of heavy ion beams while producing secondary nuclei often in high multiplicity events. The major nuclear interaction processes of importance for describing heavy ion beams was reviewed, including nuclear fragmentation, elastic scattering and knockout-cascade processes. The quantum multiple scattering fragmentation model is shown to be in excellent agreement with available experimental data for nuclear fragmentation cross sections and is studied for application to thick target experiments. A new computer model, which was developed for the description of biophysical events from heavy ion beams at the NASA Space Radiation Laboratory (NSRL), called the GCR Event Risk-Based Model (GERMcode) is described.
How strong is the evidence?
Evidence Hub reads this as a review, done in computer models (in silico), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Chaos and quantum thermalization
- The Dalton quantum chemistry program system
- Cord Blood Leptin and Adiponectin as Predictors of Adiposity in Children at 3 Years of Age: A Prospective Cohort Study
- Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes
- Stable adiabatic quantum batteries
- A novel self-lipid antigen targets human T cells against CD1c(+) leukemias
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.